Le Lézard
Classified in: Health
Subject: PLW

Holganix Receives US Patent for Microbial Bionematicide Technology


Holganix was granted a patent for microbial bionematicide technology that is environmentally friendly and shown to reduce plant parasitic nematodes by over 75% in preliminary studies.

ASTON, Pa., Oct. 13, 2022 /PRNewswire-PRWeb/ -- Holganix is an agricultural biotechnology company that develops microbial products used by farmers to increase yields, boost soil health, and reduce fertilizer requirements. Today Holganix announced it has been granted a US patent (US 11,447,427 B2) for a new microbial bionematicide technology. While studies are still ongoing, preliminary results have shown a 75% reduction in plant parasitic nematodes in a lab setting and an 80% reduction in a field setting.

The new bionematicide harnesses the power of soil microbes to reduce plant parasitic nematodes including soybean cyst, corn lesion, tomato root-knot, lance, and sting nematodes. The technology utilizes three modes of action: (1) it affects the migration of nematodes to the roots, (2) it inhibits eggs from hatching, and (3) it targets plant parasitic nematodes. The new bionematicide technology is still in development and is not yet commercialized or registered with the EPA.

"With these encouraging preliminary results and intellectual property, Holganix is positioned to develop a truly unique bionematicide product for the agriculture and turf industries," explains Holganix President of Agriculture, David Stark, Ph.D. "Nematodes represent a $100 billion problem in terms of worldwide plant loss, and current solutions are often harmful to the soil and the environment. Because Holganix's technology revolves around the use of a naturally occurring, concentrated, and stabilized stack of soil microbes, this bionematicide technology will be friendly for the environment."

The patent (patent number: US 11,447,427 B2), entitled "Methods For Controlling Pathogenic Plant Nematodes and For Improving the Health and/or Performance of Ruminant Animals," was awarded to inventors, David Stark, Ph.D., President of Agriculture at Holganix LLC and Robert Neidermyer, Ph.D., Director of Soil Health at Holganix LLC.

"We are excited that the patent agency granted protection for our novel, microbial bionematicide technology and are looking forward to continuing to develop the product, registering the product through the EPA, and commercializing it for agricultural, turf, and ornamental use," explains Stark.

About Holganix:
Holganix is a manufacturer of microbial products that harness the power of soil microbes to build soil health, improve crop yield, and reduce the need for fertilizer. Holganix products allow farmers to improve their profit per acre, giving farmers the tools they need to drive both economic and environmental sustainability on the farm.

Media Contact

Kaitlyn Ersek, Holganix LLC, 1 866-563-2784, [email protected]

Twitter

 

SOURCE Holganix LLC


These press releases may also interest you

at 23:21
Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore. This significant investment underscores the...

at 22:47
Frito Lay Canada today announced that out of an abundance of caution it is voluntarily recalling SunChips Harvest Cheddar Flavour Multigrain Snacks and Munchies Original Snack Mix. This action is the direct result of a seasoning supplier's...

at 22:10
Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy System. With this significant...

at 22:06
Meditrina, a leader in gynecologic medical devices, announced today the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.  With an extensive career in medical device sales, including a role as...

at 21:10
Aurora Spine Corporation ("Aurora Spine" or the "Company") , a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2024. All figures...

at 20:43
PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business...



News published on and distributed by: